Tudor Investment Corp Et Al Invests $21.19 Million in AbbVie Inc. (NYSE:ABBV)

Tudor Investment Corp Et Al purchased a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 157,285 shares of the company’s stock, valued at approximately $21,191,000. Several other hedge funds have also made changes […]

Related Keywords

Venclexta Venclyxto ,Raymond James ,Abbvie Inc ,Barclays ,Goepper Burkhardt ,Syntax Advisors ,Sand Hill Global Advisors ,Abbvie Company Profile ,Vantage Consulting Group Inc ,Tudor Investment Corp Et Al ,Deutsche Bank Aktiengesellschaft ,Sonen Capital ,Free Report ,Consulting Group Inc ,Hill Global Advisors ,Bank Aktiengesellschaft ,Get Free Report ,Vie Inc ,Visit Holdingschannel ,Abbvie Daily ,Abbvie ,Nyse Abbv ,Abbv ,Medical ,00287y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,